Filip Janku Selected Research

Filip Janku Research Topics

Disease

176	Neoplasms (Cancer) 12/2023 - 08/2005
14	Melanoma (Melanoma, Malignant) 11/2023 - 08/2005
13	Breast Neoplasms (Breast Cancer) 12/2023 - 10/2004
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 10/2004
12	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 03/2011
11	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2011
10	Fatigue 12/2023 - 11/2016
9	Thrombocytopenia (Thrombopenia) 10/2021 - 12/2006
8	Exanthema (Rash) 12/2023 - 02/2015
8	Diarrhea 12/2023 - 12/2006
8	Disease Progression 01/2023 - 03/2014
8	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 03/2011
7	Nausea 11/2023 - 09/2015
7	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 03/2012
6	Vomiting 10/2022 - 09/2015
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2021 - 03/2013
6	Triple Negative Breast Neoplasms 03/2020 - 12/2014
5	Cholangiocarcinoma 01/2023 - 01/2013
5	Neutropenia 10/2021 - 12/2006
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 06/2017
4	Hypoxia (Hypoxemia) 01/2023 - 11/2011
4	Erdheim-Chester Disease 01/2023 - 06/2014
4	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2013
4	Hodgkin Disease (Hodgkin's Disease) 11/2020 - 01/2014
3	Endometrial Neoplasms (Endometrial Cancer) 02/2024 - 05/2014
3	Leiomyosarcoma 12/2023 - 12/2016
3	Histiocytosis 01/2023 - 11/2010
3	Hypertension (High Blood Pressure) 01/2021 - 02/2015
3	Carcinoma (Carcinomatosis) 12/2020 - 12/2013
3	Carcinogenesis 09/2017 - 01/2011
3	Prostatic Neoplasms (Prostate Cancer) 07/2015 - 03/2014
2	Hyperglycemia 12/2023 - 01/2019
2	Dermatitis 11/2023 - 01/2018
2	Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell) 01/2023 - 01/2019
2	Sinus Histiocytosis (Rosai-Dorfman Disease) 01/2023 - 01/2019
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2022 - 08/2010
2	Constipation 10/2022 - 10/2020
2	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2011
16	Bevacizumab (Avastin)FDA Link 01/2020 - 11/2011
13	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2011
13	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 01/2011
12	Everolimus FDA Link 02/2023 - 05/2014
12	Cell-Free Nucleic AcidsIBA 10/2021 - 01/2015
10	MTOR InhibitorsIBA 11/2020 - 03/2012
8	VemurafenibIBA 02/2023 - 07/2014
8	Circulating Tumor DNAIBA 01/2023 - 05/2017
8	Proteins (Proteins, Gene)FDA Link 07/2021 - 05/2015
8	temsirolimus FDA Link 01/2018 - 11/2011
7	Carboplatin (JM8)FDA LinkGeneric 02/2023 - 06/2014
7	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2013
7	selinexorIBA 04/2022 - 08/2017
6	Paclitaxel (Taxol)FDA LinkGeneric 02/2023 - 10/2004
6	Phosphotransferases (Kinase)IBA 01/2023 - 09/2011
6	CytokinesIBA 01/2023 - 05/2014
6	pembrolizumabIBA 01/2022 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2013
6	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2014
6	ErbB Receptors (EGF Receptor)IBA 01/2020 - 09/2011
5	Sorafenib (BAY 43-9006)FDA Link 02/2023 - 04/2014
5	Monoclonal AntibodiesIBA 12/2022 - 03/2014
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2016
5	Trastuzumab (Herceptin)FDA Link 01/2021 - 10/2004
5	pazopanib FDA Link 01/2021 - 06/2015
5	Immune Checkpoint InhibitorsIBA 12/2020 - 12/2017
4	CreatinineIBA 12/2023 - 06/2015
4	CrizotinibIBA 02/2023 - 01/2018
4	ripretinibIBA 01/2023 - 01/2019
4	Vorinostat FDA Link 11/2020 - 10/2016
4	Histone Deacetylase InhibitorsIBA 11/2020 - 03/2014
4	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020 - 05/2014
4	Formaldehyde (Formol)FDA Link 01/2019 - 04/2014
4	ParaffinIBA 01/2019 - 04/2014
4	Estrogen ReceptorsIBA 01/2019 - 05/2015
4	Lenalidomide (CC 5013)FDA Link 01/2018 - 12/2013
4	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 08/2005
3	trametinibIBA 01/2023 - 02/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 10/2004
3	Pemetrexed (MTA)FDA Link 02/2022 - 12/2006
3	liposomal doxorubicin (Doxil)FDA Link 01/2022 - 11/2011
3	Hormones (Hormone)IBA 01/2021 - 05/2015
3	Sirolimus (Rapamycin)FDA Link 11/2020 - 08/2015
3	ivosidenibIBA 10/2020 - 01/2019
3	TOR Serine-Threonine KinasesIBA 01/2018 - 05/2014
3	Lapatinib (GW572016)FDA Link 11/2017 - 02/2015
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2015 - 12/2006
2	Metformin (Glucophage)FDA LinkGeneric 12/2023 - 01/2016
2	Gemcitabine FDA Link 01/2023 - 01/2018
2	InterferonsIBA 01/2023 - 01/2010
2	AntibodiesIBA 12/2022 - 03/2020
2	Topotecan (Hycamtin)FDA LinkGeneric 04/2022 - 10/2021
2	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 01/2022 - 01/2021
2	ADI PEG20IBA 01/2022 - 01/2021

Therapy/Procedure

110	Therapeutics 02/2023 - 10/2004
15	Immunotherapy 12/2022 - 12/2017
14	Drug Therapy (Chemotherapy) 02/2023 - 01/2014
9	Precision Medicine 03/2021 - 12/2008
4	Time-to-Treatment 10/2021 - 02/2015
3	Aftercare (After-Treatment) 01/2022 - 01/2012
2	Injections 01/2023 - 01/2021